Clinical trial
Efficacy and Safety of Ginkgo Biloba Extract in Mild Cognitive Impairment and…
NCT00446485 · Milsing d.o.o., Other · Completed
Key facts
| NCT number | NCT00446485 |
|---|---|
| Title | Efficacy and Safety of Ginkgo Biloba Extract in Mild Cognitive Impairment and Cerebrovascular Insufficiency |
| Official title | Efficacy and Safety of Ginkgo Biloba Standardized Extract (24% Ginkoflavonoglicozides and 6% Terpenes) in Treatment of Mild Cognitive and Concentration Impairment |
| Lead sponsor | Milsing d.o.o., Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Mild Cognitive Impairment, Cerebrovascular Insufficiency |
| Intervention type | Drug |
| Interventions | Ginkgo biloba standardized extract 24/6, Ginkgo Biloba standardized extract 24/6, placebo |
| Enrollment | 90 |
| Start date | May 1, 2007 |
| Primary completion | Apr 1, 2010 |
| Completion | Apr 1, 2010 |
| First posted | Mar 13, 2007 |
| Last update posted | Sep 28, 2015 |
| Countries | Croatia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: